Correlation Between Seer and Nuvectis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seer and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seer Inc and Nuvectis Pharma, you can compare the effects of market volatilities on Seer and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and Nuvectis Pharma.

Diversification Opportunities for Seer and Nuvectis Pharma

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Seer and Nuvectis is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Seer i.e., Seer and Nuvectis Pharma go up and down completely randomly.

Pair Corralation between Seer and Nuvectis Pharma

Given the investment horizon of 90 days Seer Inc is expected to generate 0.31 times more return on investment than Nuvectis Pharma. However, Seer Inc is 3.2 times less risky than Nuvectis Pharma. It trades about 0.17 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about -0.01 per unit of risk. If you would invest  203.00  in Seer Inc on October 6, 2024 and sell it today you would earn a total of  44.00  from holding Seer Inc or generate 21.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Seer Inc  vs.  Nuvectis Pharma

 Performance 
       Timeline  
Seer Inc 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Seer Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady technical and fundamental indicators, Seer reported solid returns over the last few months and may actually be approaching a breakup point.
Nuvectis Pharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvectis Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting fundamental indicators, Nuvectis Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Seer and Nuvectis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seer and Nuvectis Pharma

The main advantage of trading using opposite Seer and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.
The idea behind Seer Inc and Nuvectis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Volatility Analysis
Get historical volatility and risk analysis based on latest market data